Stocks Merck & Co Inc

  • graphic_final_trade.jpg

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • Stocks ended mixed Monday, capping a dismal quarter and first half marked by rocketing oil prices and battered financials. The Dow is down 14 percent since the beginning of the year and ended the first half about 20 points from bear-market territory.

  • graphic_word_ofthe_street.jpg

    After hours Morgan Stanley recommended investors buy Lehman Brothers stock and set a price target of $31. What's the "Word on the Street?"

  • graphic_final_trade.jpg

    Here's our Fast Money Final Trade. Our gang gives you Monday's best trades, right now!

  • graphic_word_ofthe_street.jpg

    Better keep your wits about you, it looks like we’re entering bear territory. What's the "Word on the Street?"

  • merck_sign.jpg

    On another ugly day for the stock markets, beaten down shares of Dow component Merck rallied. The stock started picking up steam after the news broke late this morning that its late-stage experimental migraine headache drug essentially works just as well as an existing drug, but with fewer side effects.

  • Stocks limped to the finish of an ugly week on Wall Street, with the Dow touching bear territory and the broader market continuing to be battered by a double dose of surging oil and a fresh round of banking troubles.

  • graphic_final_trade.jpg

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • Were any stocks unfairly punished in Thursday's market sell-off?

  • graphic_fast_money.jpg

    Here's how you can play healthcare with either a McCain or Obama presidency!

  • FDA

    For the second time in three days the Food and Drug Administration has delayed making a decision on drugs that it had put on a fast track. First, the agency put off a ruling on Lilly's bloodthinner Effient and then this morning Merck announced the FDA is not ready to approve its cervical cancer vaccine Gardasil for older women.

  • merck_HQ2.jpg

    U.S. regulators did not approve Merck & Co's application to expand marketing of its cervical cancer vaccine Gardasil to an older group of women within an expected review period, the drugmaker said.

  • graphic_word_ofthe_street.jpg

    The Dow closed lower on Tuesday with stocks slipping on concerns about the economy after consumer confidence fell to a 16-year low. What's the "Word on the Street?"

  • Cramer makes the call on viewers' favorite stocks.

  • graphic_fast_fire.jpg

    Sometimes a stock is hot and other time it just burns. Following are the Fast Money misfires..

  • The Lightning Round is extended in this CNBC.com exclusive feature.

  • Today, the dollar index traded at its highest levels since February, certainly above its recent range, and it did not drop commodities. Maybe a sustained rally will, but this theory has got some holes short-term.

  • Despite considerable jawboning, the dollar was weak, commodities were strong, and that combination has not proven to be helpful to stocks. With oil near new highs, the Dow Transports dropped nearly 5 percent for the second time in four days (ouch!)

  • Stocks struggled to hold gains Tuesday as bank stocks rallied but comments from Bernanke hung over the market like a cloud. Oil dropped more than $3 to settle at $131.31 a barrel.

  • Everyone talking about Pfizer's spacer huge 7.1 percent dividend yield, which gets bigger every day because the stock keeps dropping. Is it safe?